Mike Ravenscroft is the new managing director of the $16m Maryland Momentum Fund, replacing Claire Broido Johnson.

David Neustaedter, the 14-year corporate venturing veteran, has left his VP position at Medtronic and joined an undisclosed investment firm.

Reliance Egypt participated in Trukker’s $100m series C round while Merck, Eli Lilly and Heritage Medical all backed Photys’ $75m series A.

SoftBank, Bristol Myers Squibb and Hitachi were among Arsenal Biosciences’ $220m round while MegaChips led a $140m round for Morse Micro.

SHV and DELA took part in an $80m round for Lightyear while Tata Sons provided $40m in funding for Tata 1mg.

Charbel Rizk has spun Oculi out of Johns Hopkins University to commercialise technology that gives computer vision the capabilities of the human eye.

Eli Lilly took part in a $50m series A1 round for Neukio Biotherapeutics while Itochu led Docquity’s $44m series C.

SK has provided $50m in funding for Ascend Elements while ServiceNow took part in a $35.6m series C round for Fairmarkit.

Telus's strategic investment arm plans to extend its presence outside of Canada while continuing to bet on areas like agriculture and health.

Peijia Medical participated in JenaValve’s $100m series C round while L Catterton led Planted Foods’ series B extension, lifting it to $93m.